Runway Growth Finance Corp. Reports Q4 2025 Earnings, Misses Estimates, and Anticipates SWK Acquisition Close

RWAY
March 13, 2026

Runway Growth Finance Corp. (RWAY) reported fourth‑quarter 2025 investment income of $30.0 million, down from $33.8 million in Q4 2024, and net investment income of $11.6 million, compared with $14.6 million a year earlier. Earnings per share fell to $0.32, missing the consensus estimate of $0.36 and the year‑ago EPS of $0.39. Total investment income and net income were also lower than the $36.7 million and $15.7 million reported in Q3 2025, indicating a sequential decline.

The investment portfolio was valued at $927.4 million, consisting of $860.3 million in senior‑secured loans and $67.1 million in warrants and other equity‑related investments. Net assets increased by $7.4 million, or $0.20 per share, to a net asset value of $13.42 per share.

Management attributed the earnings miss to a combination of headwinds. Lower base rates, portfolio turnover, and credit‑related issues reduced investment income, while one‑time charges from debt redemptions added pressure. Thomas Ratterman, CFO and COO, said, "We generated total investment income of $30 million and net investment income of $11.6 million in the fourth quarter of 2025, a decrease compared to $36.7 million and $15.7 million in the third quarter of 2025."

Looking ahead, RWAY expects the SWK Holdings acquisition to close in early April. The modest delay in timing will contribute to some softness in Q1 2026 earnings, with a projected $0.02 headwind from one‑time charges, according to Ratterman. David Spreng, Founder and CEO, added, "Our transaction with SWK is now expected to close in early April. Our confidence in closing this transaction remains unchanged. One key aspect of our transaction with SWK is the diversification it will bring to our portfolio." Spreng also noted, "Our pipeline is stronger than it was at this point last year, giving us measured optimism for the remainder of 2026."

Strategically, RWAY continues to integrate the BC Partners platform and leverages the SWK acquisition to expand its healthcare and life‑sciences exposure from 14% to roughly 31%. The company believes its earnings power remains aligned with the current distribution level of $0.33 per share, supported by an 89.8% payout ratio and a 17% annualized dividend yield.

Investors reacted to the earnings miss with a muted market response, reflecting concerns over the lower-than‑expected income while acknowledging management’s confidence in the pipeline and the anticipated benefits of the SWK transaction.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.